Cargando…
Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis
Autores principales: | Hušáková, Markéta, Bay-Jensen, Anne-C., Forejtová, Šárka, Zegzulková, Kateřina, Tomčík, Michal, Gregová, Monika, Bubová, Kristýna, Hořínková, Jana, Gatterová, Jindra, Pavelka, Karel, Siebuhr, Anne Sofie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438514/ https://www.ncbi.nlm.nih.gov/pubmed/32814796 http://dx.doi.org/10.1038/s41598-020-71093-9 |
Ejemplares similares
-
Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis
por: Hušáková, Markéta, et al.
Publicado: (2019) -
Cross-sectional study of patients with axial spondyloarthritis fulfilling imaging arm of ASAS classification criteria: baseline clinical characteristics and subset differences in a single-centre cohort
por: Bubová, Kristyna, et al.
Publicado: (2019) -
Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis
por: Prajzlerová, Klára, et al.
Publicado: (2017) -
S100A4 is elevated in axial spondyloarthritis: a potential link to disease severity
por: Šumová, Barbora, et al.
Publicado: (2020) -
Effect of group-based physiotherapy on pain and depression in patients with axial spondyloarthritis and non-specific low back pain: data of 1-year follow-up
por: Hušáková, Markéta, et al.
Publicado: (2023)